Articles

For type-2 diabetic patients with inadequate blood glucose control despite treatment with two oral diabetes drugs, the addition of either insulin glargine or rosiglitazone results in comparable levels of improvement in glucose control, investigators report.

Past studies in tissue culture have suggested that one type of pancreas cell could be coaxed to transform into insulin-producing islet cells.

Exenatide added to thiazolidinediones improved glycemic control and reduced body weight in some patients with type 2 diabetes, according to the results of a randomized, double-blind, placebo-controlled trial.

Results from a Phase 2A study showed that the data lends support to the concept that abnormalities in cortisol activity may play an important role in the causation of type 2 diabetes and metabolic syndrome, a cluster of co-morbidities commonly associated with type 2 diabetes and insulin resistance.

Results showed that Emisphere’s eligen(R) technology can orally deliver the incretin hormones GLP-1 and PYY. The oral administration of both peptides induced a rapid and dose-dependent, statistically significant increase in plasma drug concentrations at all doses tested versus placebo.

A Melbourne 11-year old schoolboy is the first person in the world to take a pioneering vaccine against diabetes.

Women who take low to moderate doses of aspirin have a reduced risk of death from any cause, and especially heart disease–related deaths, according to a new report.

Researchers have now carefully crafted a combination therapy that reverses recent-onset type 1 diabetes in 2 animal models of disease.

People with high cholesterol levels and taking statins reduced their frequency of major cardiac events by about 20 per cent when supplemented with the omega-3 of eicosapentaenoic acid (EPA), researchers have reported.

A peptide developed by scientists at Weill Cornell Medical College may expand the availability and durability of islet cell transplant for patients with type-1 diabetes.